A new drug that slows the pace of Alzheimer’s disease is too expensive for too little benefit to be used on the NHS, the watchdog says.
The voice of the Punjabi community across the UK, Europe and Beyond.
The voice of the Punjabi community across the UK, Europe and Beyond.
A new drug that slows the pace of Alzheimer’s disease is too expensive for too little benefit to be used on the NHS, the watchdog says.